PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $93,960 | -27.2% | 10,800 | -0.6% | 0.00% | – |
| Q3 2022 | $129,000 | -17.8% | 10,862 | -0.8% | 0.00% | – |
| Q2 2022 | $157,000 | -32.0% | 10,950 | -1.4% | 0.00% | – |
| Q1 2022 | $231,000 | -7.2% | 11,102 | +2.6% | 0.00% | – |
| Q4 2021 | $249,000 | -95.2% | 10,817 | -93.7% | 0.00% | -100.0% |
| Q3 2021 | $5,147,000 | -30.7% | 172,726 | -20.5% | 0.00% | -50.0% |
| Q2 2021 | $7,422,000 | -6.3% | 217,264 | -9.8% | 0.00% | 0.0% |
| Q1 2021 | $7,923,000 | -58.0% | 240,919 | -21.4% | 0.00% | -60.0% |
| Q4 2020 | $18,854,000 | +32.8% | 306,509 | -23.4% | 0.01% | 0.0% |
| Q3 2020 | $14,200,000 | – | 400,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |